Vital Therapies reported $0 in Loan Capital for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Biomarin Pharmaceutical BMRN:US $ 1081.05M 0.99M
Dynavax Technologies DVAX:US $ 221.03M 0.27M
Enanta Pharmaceuticals ENTA:US $ 1.51M 0M
Epizyme EPZM:US $ 232.9M 411K
Insmed INSM:US $ 807.11M 447K
Intercept Pharmaceuticals ICPT:US $ 713.86M 3.03M
Mirati Therapeutics MRTX:US $ 0M 0M
Regulus Therapeutics RGLS:US $ 3.59M 1.08M
Revance Therapeutics RVNC:US $ 378.38M 52.48M
Ultragenyx Pharmaceutical RARE:US $ 0M 0M
United Therapeutics UTHR:US $ 800M 0M
Vital Therapies VTL:US $ 0M 0M
Xoma XOMA:US $ 0 0